It's Time to Move Forward

Corporate Headquarters

NanoString Technologies, Inc.
530 Fairview Avenue North
Seattle, WA 98109

Directions and Map

Phone 888-358-NANO (888-358-6266)

Fax: 206-378-6288



Request Information

Area(s) of Interest
Check all that apply

Subscribe to our mailing list

Privacy Policy

Prosigna is indicated for in vitro diagnostic use in postmenopausal women with hormone receptor-positive, node-negative (Stage I or II), or node-positive (Stage II) breast cancer to be treated with adjuvant endocrine therapy for assessment of risk of distant recurrence of disease.